- Current Rating
- Weak Setup
- Opportunity Score
- 48/100
- Risk Level
- High
- Best Action
- Add to watchlist and monitor for confirmation
Why: VRAX is trading near recent levels (+2.4% today). Overall, the company is reasonably solid. The long-term trend is down, which raises the bar for any bullish setup. Short-term momentum is still weak, so confirmation is needed before acting. Risk is elevated — size carefully and require confirmation.
What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.
Avoid if: Price breaks below support on heavy volume or company guidance weakens.
Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.
Research only — not financial advice. Olmem never executes trades.
News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.
- VRAX SEC Filings - Virax Biolabs Group Ltd 10-K, 10-Q, 8-K Forms - Stock TitanStock Titan · 7/13/2026
- Virax Biolabs (Nasdaq: VRAX) secures $3.3M and issues new equity warrants - Stock TitanStock Titan · 7/10/2026
- $3.3M cash in, new Virax Biolabs warrants out at $6 a share - Stock TitanStock Titan · 7/10/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market Session - BenzingaBenzinga · 7/10/2026
- Virax Biolabs locks in $3.3M from option exercise deal - Stock TitanStock Titan · 7/9/2026
- 12 Health Care Stocks Moving In Thursday's Intraday Session - BenzingaBenzinga · 7/9/2026
- Nasdaq Gains 100 Points; US Initial Jobless Claims Edge Lower - BenzingaBenzinga · 7/9/2026
Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.